Entity Common Stock, Shares Outstanding of GUIDED THERAPEUTICS INC from 15 Aug 2011 to 10 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
GUIDED THERAPEUTICS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Aug 2011 to 10 Nov 2025.
  • GUIDED THERAPEUTICS INC Entity Common Stock, Shares Outstanding for the quarter ending 10 Nov 2025 was 83,599,156, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 83,599,156 +22,583,919 +37% 10 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 80,283,991 +23,733,621 +42% 11 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 77,967,594 +22,354,145 +40% 18 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 61,015,237 +8,919,116 +17% 11 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 56,550,370 +5,261,433 +10% 10 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 55,613,449 +5,107,986 +10% 28 Mar 2024 10-K 28 Mar 2024 2023 FY
Q3 2023 52,096,121 +3,517,400 +7.2% 09 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 51,288,937 10 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 50,505,463 +28,441,468 +129% 27 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 48,578,721 +34,945,138 +256% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q1 2022 22,063,995 +8,883,578 +67% 15 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 13,633,583 +537,394 +4.1% 10 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 13,296,880 +1,032,251 +8.4% 10 Aug 2021 10-Q 18 Aug 2021 2021 Q2
Q1 2021 13,180,417 +1,872,226 +17% 05 Apr 2021 10-K 07 Apr 2021 2020 FY
Q3 2020 13,096,189 01 Nov 2020 10-Q/A 05 Nov 2020 2020 Q3
Q2 2020 12,264,629 +8,945,143 +269% 03 Jul 2020 10-Q 07 Jul 2020 2020 Q1
Q1 2020 11,308,191 +7,988,705 +241% 07 Apr 2020 10-K 20 Apr 2020 2019 FY
Q4 2019 3,319,486 07 Feb 2020 10-Q 11 Feb 2020 2019 Q2
Q2 2019 3,319,486 -291,845,614 -99% 17 Jun 2019 10-Q 11 Jul 2019 2019 Q1
Q1 2019 3,319,486 -140,593,452 -98% 15 Apr 2019 10-K 08 May 2019 2018 FY
Q3 2018 479,249,998 +459,796,529 +2364% 09 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 295,165,100 +291,568,368 +8106% 01 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 143,912,938 +142,807,926 +12924% 08 Apr 2018 10-K/A 20 Apr 2018 2017 FY
Q3 2017 19,453,469 07 Nov 2017 10-Q 20 Nov 2017 2017 Q3
Q2 2017 3,596,732 -150,323,154 -98% 07 Aug 2017 10-Q 18 Aug 2017 2017 Q2
Q1 2017 1,105,012 -2,048,179 -65% 06 Mar 2017 10-K 22 Mar 2017 2016 FY
Q4 2016 570,707 30 Nov 2016 10-Q 05 Dec 2016 2016 Q3
Q2 2016 153,919,886 +40,380,644 +36% 11 Aug 2016 10-Q 17 Aug 2016 2016 Q2
Q1 2016 3,153,191 -94,031,150 -97% 07 Mar 2016 10-K 15 Mar 2016 2015 FY
Q3 2015 163,741,755 +83,838,316 +105% 30 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 113,539,242 +38,043,773 +50% 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 97,184,341 +25,460,378 +35% 16 Mar 2015 10-K 25 Mar 2015 2014 FY
Q3 2014 79,903,439 +13,599,443 +21% 04 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 75,495,469 09 Aug 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 71,723,963 +6,901,983 +11% 20 Mar 2014 10-K 26 Mar 2014 2013 FY
Q3 2013 66,303,996 +4,116,675 +6.6% 11 Nov 2013 10-Q 13 Nov 2013 2013 Q3
Q1 2013 64,821,980 +12,388,103 +24% 26 Mar 2013 10-K 27 Mar 2013 2012 FY
Q3 2012 62,187,321 +13,591,136 +28% 09 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 61,346,676 07 Aug 2012 10-Q/A 24 Aug 2012 2012 Q2
Q1 2012 52,433,877 06 Mar 2012 10-K 28 Mar 2012 2011 FY
Q3 2011 48,596,185 15 Aug 2011 10-Q 14 Nov 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.